Phase 1 clinical trials in oncology are essential to the natural progression of any clinical compound or device, but remain some of the most unique and challenging trials that a research site can embark on. Given the tremendous amount of nuance that exists in these trials compared to later phase trials, the SCRS Oncology Education Committee developed a resource to guide sites that wish to expand their offerings into Phase 1. This document outlines several of the major considerations that a site should explore when considering Phase 1 oncology trials. Many of these aspects are also applicable to other therapeutic areas, but most pertain to oncology trials. Additional resources are and will be made available to supplement this document and give sites looking to venture into Phase 1 studies a solid foundation.
Practice & Patients by ASCO
The American Society of Clinical Oncology (ASCO) provides exemplary education and resources to support oncology practices and promote the delivery of high-quality, high-value cancer care.